Status:
UNKNOWN
Association Between Thyroid Dysfunction and Intensive Care Unit Acquired Weaknesss
Lead Sponsor:
Ain Shams University
Conditions:
Thyroid Abnormalities
ICU Acquired Weakness
Eligibility:
All Genders
18+ years
Brief Summary
Intensive care unit-acquired weakness (ICU-AW) is the most common neuromuscular impairment in critically ill patients. It affects more than 50 % of patients in the intensive care and is related to man...
Detailed Description
Intensive care unit acquired weakness refers to muscle weakness encountered in the intensive care unit as a consequence of critical illness. It affects more than 50 % of patients in the intensive care...
Eligibility Criteria
Inclusion
- Patients of both sexes admitted to the general ICU of Ain Shams University Hospitals with critical illness for more than 7 days \* Diagnosis of ICU acquired weakness will be made based on clinical criteria for ICUAW and confirmed by nerve conduction studies.
Exclusion
- Patients with cerebrovascular accidents, neuromuscular disorders, spine abnormalities, spinal cord or head injuries, CNS tumors, secondary thyroid disorders and electrolyte disturbances were excluded from the study. Patients receiving thyroid replacement or anti-thyroid drugs for the treatment of any throid disorder will be also excluded from the study as these drugs may alter their thyroid biochemistry
Key Trial Info
Start Date :
February 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04313101
Start Date
February 20 2020
End Date
May 1 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University hospitals
Cairo, Abbaseya, Egypt, 11566